Generate a tailored SOP for Dr. Naftali Kaminski. Improve your application with a focused, well-structured draft.
Dr. Naftali Kaminski is the Boehringer-Ingelheim Endowed Professor of Internal Medicine and Section Chief of Pulmonary, Critical Care & Sleep Medicine at Yale School of Medicine. He holds a strong expertise in the field of idiopathic pulmonary fibrosis (IPF) and chronic lung diseases. After earning his MD from Hebrew University in 1989, Dr. Kaminski completed his residency at Hadassah Mount-Scopus University Hospital and a fellowship in pulmonary medicine at Sheba Medical Center in Israel. He has pioneered research in genomic approaches to understand the mechanisms underlying advanced lung diseases, leading to significant advancements in diagnostics and therapeutic strategies for conditions like IPF, chronic obstructive pulmonary disease (COPD), and severe asthma. Dr. Kaminski's leadership in the Kaminski Lab focuses on high-throughput genomic technologies and the role of microRNAs in pulmonary fibrosis, contributing to the identification of prognostic biomarkers. His impressive publication record includes over 340 research papers in prestigious journals, and he actively participates in several professional organizations, serving in editorial roles and mentoring emerging scientists. Dr. Kaminski has received numerous accolades for his contributions to pulmonary research and education, including the American Thoracic Society Recognition Scientific Achievements Award and the Yale Blavatnik Innovation Award.
Yale School of Medicine • New Haven, CT
Professor of Internal Medicine and Section Chief of Pulmonary, Critical Care & Sleep Medicine.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.